Načítá se...

Meningococcal factor H-binding protein vaccines with decreased binding to human complement factor H have enhanced immunogenicity in human factor H transgenic mice

Factor H-binding protein (fHbp) is a component of a meningococcal vaccine recently licensed in Europe for prevention of serogroup B disease, and a second vaccine in clinical development. The protein specifically binds human factor H (fH), which down-regulates complement activation and enhances resis...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Rossi, Raffaella, Granoff, Dan M., Beernink, Peter T.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2013
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3867019/
https://ncbi.nlm.nih.gov/pubmed/24035433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.08.099
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!